GAMMA Investing’s Sanara MedTech SMTI Stock Holding History

GAMMA Investing’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.81K	Hold	80	–	–	﹤0.01%	3859
2026 Q2	$1.89K	Hold	80	–	–	﹤0.01%	3736
2026 Q1	$1.37K	Buy	+80	New	+$1.65K	﹤0.01%	3764
2025 Q4	–	Sell	-11	Closed	-$349	–	4132
2025 Q3	$349	Sell	11 -2	-15%	-$60	﹤0.01%	3753
2025 Q2	$369	Sell	13 -45	-78%	-$1.35K	﹤0.01%	3674
2025 Q1	$1.79K	Buy	58 +37	+176%	+$1.26K	﹤0.01%	3437
2024 Q4	$697	Buy	+21	New	+$712	﹤0.01%	3517

Other funds holding SMTI

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's SMTI Position: Q3 2026 in Review

GAMMA Investing held its Sanara MedTech (SMTI) position steady in Q3 2026 at 80 shares worth $2.81K. The position accounts for ﹤0.01% of the portfolio, ranked #3859.

GAMMA Investing first reported a position in SMTI in Q4 2024 and has held it in 7 quarters since. 2 funds tracked by Wall St. Rank hold SMTI as of Q3 2026.

GAMMA Investing held 80 shares of Sanara MedTech worth $2.81K as of Q3 2026.
GAMMA Investing left its Sanara MedTech share count unchanged in Q3 2026.
Sanara MedTech made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3859 holding.
GAMMA Investing first reported a position in Sanara MedTech in Q4 2024 and has held it in 7 quarters since.
2 funds tracked by Wall St. Rank held Sanara MedTech as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.